Document:

EX-10.5

 Exhibit 10.5 

ZIMVIE INC. 
 EXECUTIVE
ANNUAL INCENTIVE PLAN 
 (Effective as of January 1, 2022) 

1. Purpose: The purpose of the ZimVie Inc. Executive Annual Incentive Plan (the “Plan”) is to promote the interests of the
Company and its stockholders by providing additional compensation as incentive to certain key executives who contribute materially to the success of the Company and its Subsidiaries and Affiliates. 

2. Definitions: The following terms when used in the Plan shall, for the purposes of the Plan, have the following meanings: 

“Affiliate” means any entity in which the Company has a direct or indirect ownership interest of at least 20%. 

“Adjusted” refers to operating performance measures that have been adjusted to exclude the effects of certain items or events that
occur or otherwise impact reported results during a performance period, as approved by the Committee and disclosed from time to time in the Company’s quarterly or annual earnings releases. 

“Award” means the compensation payable to a Participant as described in Section 5. 

“Board” means the Board of Directors of ZimVie Inc. 

“Code” means the Internal Revenue Code of 1986, as amended, and its interpretive rules and regulations. 

“Company” means ZimVie Inc., its Subsidiaries and Affiliates. 

“Committee” the committee designated by the Board to administer the Plan as provided in Section 3. It is intended that the
Committee will be the Compensation and Management Development Committee of the Board of Directors of ZBH until the date that ZimVie Inc. ceases to be a subsidiary of ZBH. Thereafter, it is intended that the Committee will be the Compensation
Committee of the Board. 
 “Disability” means total disability as defined by the Company’s group long-term disability
insurance policy applicable to Participants. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and its
interpretive rules and regulations. 
 “Executive Officer” means a Participant who has been designated by the Board as an
executive officer pursuant to Rule 3b-7 under the Exchange Act. 
 “Final Payment Date”
means, with respect to Awards for a Fiscal Year, the date that the final Awards are paid to Participants after the end of the Fiscal Year. 

“Fiscal Year” means a fiscal year of the Company. 

“Participant” means a key executive of the Company chosen to participate in the Plan in any applicable Fiscal Year. 

“Plan” means this document as it may be amended from time to time. 

“Regulations” means rules and regulations adopted by the Committee pursuant to Section 3. 

“Retirement” means a Participant’s voluntary termination of employment with the Company on or after the earlier of (i) the
Participant’s 65th birthday, or (ii) the date as of which the Participant has both attained 55 years of age and completed 10 years of service with the Company. For Plan purposes,
Participants’ prior employment with ZBH and its affiliates will constitute service with the Company. 
 “Section 409A
Standards” means the applicable requirements and standards for non-qualified deferred compensation plans established by Code Section 409A. 

 “Separation from Service” means a Participant’s death, Retirement, or
termination of employment with the Company. Whether a Separation from Service has occurred will be determined in accordance with the Section 409A Standards, including §1.409A-1(h). 

“Specified Employee” has the meaning given in Code Section 409A(a)(2)(B)(i). The determination of which individuals are
Specified Employees will be made in accordance with such rules and practices, consistent with the Section 409A Standards, as are established from time to time by the Board or its designee. 

“Subsidiary” means any corporation that at the time qualifies as a subsidiary of the Company under the definition of
“subsidiary corporation” in Code Section 424. 
 “Unforeseeable Emergency” means a severe financial hardship to the
Participant resulting from an illness or accident of the Participant, the Participant’s spouse, or the Participant’s dependent (as defined in Code Section 152, without regard to Sections 152(b)(1), (b)(2), and (d)(1)(B)); loss of the
Participant’s property due to casualty; or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the Participant’s control. 

“ZBH” means Zimmer Biomet Holdings, Inc. 

3. Administration: The Plan shall be administered under the supervision of the Board, which may exercise its powers, to the extent
herein provided, through the agency of the Committee. 
 The Committee, from time to time, may adopt Regulations for carrying out the
provisions and purposes of the Plan and make such determinations, not inconsistent with the terms of the Plan, as the Committee deems appropriate. The Committee may alter, amend or revoke any Regulation adopted. 

The authority of the Committee shall include the right to exercise discretion at any time prior to the payment of an Award to increase an
Award subject to the maximum provided in Section 7 or reduce the Award to any amount, including zero, that is below the computed amount of the Award. The reduction of the Award to one or more Participants shall not have the effect of increasing
the Award payable to any other Participant. 
 The Committee may delegate its responsibilities for administering the Plan with respect to
Participants who are not Executive Officers to a committee of two or more Executive Officers. Any Awards under the Plan to members of this committee shall be referred to the Committee or Board for approval. 

4. Participation: 
 (a)
Committee Determinations. For each Fiscal Year, the Committee shall determine the names of those key executives who will be Participants for the Fiscal Year. 

(b) Addition of Participants. The Committee may determine that a key executive should be designated a Participant after the commencement
of a Fiscal Year due to commencement of employment or promotion. In such event, the Committee may make an Award to such a Participant for a portion of the remainder of the Fiscal Year commencing on the date as of which such Participant was employed
or promoted. 
 (c) Termination of Participants. A key executive shall cease to be a Participant upon Separation of Service for any
reason. 
 5. Determination of Performance Measures and Targets: For each Fiscal Year, the Committee shall determine: 

(a) The performance measures that will be used to determine the Awards to Participants, which may include one or more of the following, either
reported or Adjusted, and either individually, alternatively or in any combination: net sales; revenue; gross profit; operating profit; net earnings; earnings per share; profit margin (gross, operating or net); cash flow, net cash flow or free cash
flow; acquisition integration synergies (measurable savings and efficiencies resulting from integration); acquisition integration milestone achievements; stock price performance; total stockholder return; expense reduction; debt or net debt
reduction; financial return ratios (including return on equity, return on assets or net assets, return on capital or invested capital and return on operating profit); earnings before interest, taxes, depreciation and amortization; earnings before
interest and taxes; quality measures; regulatory compliance measures; or any other performance measure determined by the Committee. Any of the foregoing performance measures may be subsequently adjusted by the Committee to exclude the effects of
unanticipated material transactions or events such as acquisitions, divestitures, accounting changes, restructurings and special charges or gains (determined according to objective criteria established by the Committee). 

  
 - 2 - 

 (b) The specific targets for each of the selected performance measures that will determine
the amount of the Award, which may be set at a specific level or growth rate. Any targets or performance measures may be applied to the Company or any Subsidiary, or subdivision thereof, or may be expressed as relative to comparable measures at peer
companies or a defined index. 
 6. Payment of Performance Incentive Awards: 

(a) Time of Determination of Award. Subject to such forfeitures of Awards and other conditions as are provided in the Plan, the Awards
made to Participants shall be paid to them or their beneficiaries as follows: 
 (i) As soon as practicable after the end of a Fiscal Year,
the Committee shall determine the extent to which Awards have been earned on the basis of the actual performance in relation to the specific targets for the performance measures established for that Fiscal Year and shall certify in writing those
determinations. Any Award for a Fiscal Year shall be paid in a lump sum not later than 21⁄2 months after the end of the Fiscal Year. 

(ii) Except as provided in the following sentence or by a Regulation, a Participant must be employed by the Company on the Final Payment Date
with respect to an Award to be entitled to payment of such Award. If a Participant experiences a Separation from Service prior to the end of a Fiscal Year because of the Participant’s death, Disability or Retirement, the Participant or his
designated beneficiary, where applicable, shall be eligible, at the Committee’s discretion, to receive a prorated portion of any Award granted to the Participant for that Fiscal Year based upon eligible earnings paid to the Participant in such
year. 
 (iii) While no Participant has an enforceable right to receive an Award until the end of the Fiscal Year as outlined in subparagraph
(i) above, the Committee, in its discretion, may make a provisional payment of part of the Award, in accordance with the Regulations, based on tentative estimates of the amount of the Award, subject to any terms and conditions the Committee may
establish. A Participant shall be required to repay any portion or all of such provisional payments in order that the total payments may not exceed the Award as finally determined, or if the Participant shall forfeit his or her Award for any reason
during the Fiscal Year. The Committee may exclude a Participant from receiving any provisional payment pursuant to this subparagraph (iii). 

(b) Withholding. There shall be deducted from all payments of Awards any taxes required to be withheld by any government entity and paid
over to any such government in respect of any such payment. Unless otherwise elected by the Participant, such deductions shall be at the established withholding tax rate. Participants may elect to have the deduction of taxes cover the amount of any
applicable tax (the amount of withholding tax plus the incremental amount determined on the basis of the highest marginal tax rate applicable to the Participant). 

(c) Form of Payment. The Award shall be paid entirely in cash. 

7. Maximum Awards: Notwithstanding anything elsewhere in the Plan to the contrary, the maximum amount of any Award that may be payable
to a Participant in respect of any single Fiscal Year will be 400% of the Participant’s base rate of salary determined as of the beginning of such Fiscal Year. 

8. Conditions Imposed on Payment of Awards: Payment of each Award to a Participant or to the Participant’s beneficiary shall be
subject to the following provisions and conditions: 
 (a) Rights to Awards. No Participant or any person claiming under or through
the Participant shall have any right or interest, whether vested or otherwise, in the Plan or in any Award thereunder, contingent or otherwise, unless and until all of the terms, conditions and provisions of the Plan and the Regulations that affect
that Participant or such other person shall have been complied with. Nothing contained in the Plan or in the Regulations shall require the Company to segregate or earmark any cash, shares, stock, or other property. Neither the adoption of the Plan
nor its operation shall in any way affect the rights and power of the Company or any of its Subsidiaries or Affiliates to dismiss and/or discharge any employee at any time. 

  
 - 3 - 

 (b) Assignment or Pledge of Rights of Participant. No rights under the Plan,
contingent or otherwise, shall be assignable or subject to any encumbrance, pledge or charge of any nature, except that a Participant may designate a beneficiary pursuant to the provisions of Section 9. 

(c) Right to Payment. No absolute right to any Award shall be considered as having accrued to any Participant prior to the Final Payment
Date. No Participant shall have any enforceable right to receive any Award made with respect to a Fiscal Year or to retain any payment made with respect thereto if, for any reason (death included), the Participant, during such entire Fiscal Year,
has not performed his or her duties to the satisfaction of the Company. 
 9. Designation of Beneficiary: A Participant may name a
beneficiary to receive any payment to which the Participant may be entitled under the Plan in the event of the Participant’s death, on a form approved by the Committee. A Participant may change his or her beneficiary from time to time in the
same manner. 
 If no designated beneficiary is living on the date on which any payment becomes payable to a Participant’s beneficiary,
the payment will be payable to the Participant’s estate. 
 10. [Reserved] 

11. Miscellaneous: 
 (a)
Acceptance by Participant. By accepting any benefits under the Plan, each Participant and each person claiming under or through him shall be conclusively deemed to have indicated acceptance and ratification of, and consent to, any action
taken or made to be taken or made under the Plan by the Company, the Board and the Committee. 
 (b) Conclusive Actions. Any action
taken or decision made by the Company, the Board or the Committee arising out of or in connection with the construction, administration, interpretation or effect of the Plan or of the Regulations shall lie within its absolute discretion, as the case
may be, and shall be conclusive and binding upon all Participants and all persons claiming under or through any Participant. 
 (c) No
Liability. No member of the Board or the Committee shall be liable for any action or failure to act, or any action or failure to act of any other member, or of any officer, agent or employee of the Company, as the case may be, except for his or
her own actions or inactions done in bad faith. The fact that a member of the Board or the Committee shall have previously been or subsequently thereafter may be a Participant in the Plan shall not disqualify such a person from voting at any time as
a director with regard to any matter concerning the Awards, or in favor of or against any amendment or alteration of the Plan, provided that the amendment or alteration shall be of general application. 

(d) Reliance on Third Parties. The Board and the Committee may rely upon any information supplied to them by any officer of the Company
or any of its Subsidiaries or Affiliates and may rely upon the advice of counsel in connection with the administration of the Plan and shall be fully protected in relying upon information or advice. 

(e) Grounds for Recovery. After the certification of attainment of the specific targets for performance measures as described in
subparagraph 6(a)(i) above, no adjustments will be made to reflect any subsequent change in accounting, the effect of federal, state or municipal taxes later assessed or determined, or otherwise. Notwithstanding the foregoing, the Company
reserves the right to and, in appropriate cases, will, seek recovery of all or any portion of Award if: 
 (i) The amount of the Award was
calculated based upon the achievement of certain financial results that were subsequently the subject of a restatement of all or a portion of the Company’s financial statements; 

(ii) The Participant engaged in intentional misconduct that caused or partially caused the need for such a restatement; and 

(iii) The amount of the Award that would have been awarded to the Participant had the financial results been properly reported would have been
lower than the amount actually awarded. 

  
 - 4 - 

 This subsection is not intended to limit the Company’s power to take such other actions
as it deems necessary to remedy the misconduct, prevent its recurrence and, if appropriate, based on all relevant facts and circumstances, punish the wrongdoer in a manner it deems appropriate. 

(f) Other Bases for Forfeiture, Recovery or Other Actions. Awards and any compensation or benefits associated therewith shall be subject
to repayment or forfeiture as may be required to comply with (i) any applicable listing standards of a national securities exchange adopted in accordance with Section 10D of the Exchange Act (regarding recovery of erroneously awarded
compensation) and any implementing rules and regulations of the U.S. Securities and Exchange Commission adopted thereunder; (ii) similar rules under the laws of any other jurisdiction; and (iii) any policies adopted by the Company to
implement such requirements, all to the extent determined by the Company in its discretion to be applicable to a Participant. Any agreement evidencing an Award may be unilaterally amended by the Committee to comply with any such compensation
recovery policy. 
 12. Adoption, Amendment, Suspension and Termination of the Plan: 

(a) Effective Time. The Plan is effective as of January 1, 2022. 

(b) Termination and Amendment. Subject to the limitations set forth in subparagraph (c) below, the Board or its designee may at any
time suspend or terminate the Plan and may amend it from time to time in such respects as the Board or its designee may deem advisable, subject to any requirements for stockholder approval imposed by applicable law, including the Section 409A
Standards, to the extent applicable. 
 (c) Rights of Participants. No amendment, suspension or termination of the Plan shall, without
the consent of the person affected thereby, materially, adversely alter or impair any rights or obligations under any Award previously awarded under the Plan. 

13. Compliance with Section 409A Standards: It is intended that this Plan and all Awards hereunder comply with the
applicable Section 409A Standards and will be construed accordingly. In construing or interpreting any vague or ambiguous Plan provision, the interpretation that will prevail is the interpretation that will cause the Plan to comply with the
applicable Section 409A Standards. To the extent that any terms of the Plan or an Award would subject any Participant to gross income inclusion, interest, or additional tax pursuant to Code Section 409A, those terms are to that extent
superseded by the applicable Section 409A Standards. 
 14. Governing Laws: The validity, interpretation and effect of the Plan,
and the rights of all persons hereunder, shall be governed by and determined in accordance with the laws of the State of Colorado, other than the choice of law rules thereof. 

[End of Plan document.] 

  
 - 5 -EX-10.6

 Exhibit 10.6 

CORPORATE EXECUTIVE CONFIDENTIALITY, NON-COMPETITION 

AND NON-SOLICITATION AGREEMENT 

This Corporate Executive Confidentiality, Non-Competition and
Non-Solicitation Agreement (“Agreement”) is made by and between Zimmer Biomet Spine, Inc. d/b/a ZimVie, a Delaware corporation, and ___________________ (“Employee”). 

Recitals 
 A. For
purposes of this Agreement, the term “Company” means Zimmer Biomet Spine, Inc. and/or any or each of its affiliates, parents, or direct or indirect subsidiaries, as well as any successor-in-interest to Zimmer Biomet Spine, Inc. and/or to any of its direct or indirect subsidiaries, affiliates, or parents. 

B. Employee is employed or is being employed by Company in an executive and/or high-level managerial capacity in which Employee has or will
have extensive access Confidential Information of Company, and/or is being offered certain equity incentives. 
 C. Company has offered
Employee employment and/or other valuable consideration, which may include without limitation such consideration as a job promotion, an increase in compensation, participation in bonus programs, and/or an equity award, contingent upon
Employee’s entering into this Agreement. 
 Agreement 

NOW, THEREFORE, in consideration of the foregoing recitals, the promises contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, Company and Employee agree to be legally bound as follows: 
 1.
Acknowledgements. Employee acknowledges that Company is engaged in the highly competitive business of the development, manufacture, distribution, and sale of orthopedic- and musculoskeletal-related medical and surgical devices,
products, applications, and services, including, but not limited to, the following product categories: dental, spine, bone healing, surgical (including MIS solutions), and/or biologics. Employee serves or will serve in an executive and/or high-level
managerial capacity for Company and in that capacity Employee has and/or will have access to and has and/or will gain knowledge of substantial Confidential Information of Company across one or more of the Company’s product categories. 

2. Non-Disclosure and Ownership of Confidential Information. Employee acknowledges that
Confidential Information is a valuable, special, and unique asset of Company, and solely the property of Company, and agrees to the following; provided, however, that this Agreement does not, in any manner, prevent employees from filing a complaint
with, providing information to, or participating in an investigation conducted by, the Securities and Exchange Commission, the United States Equal Opportunity Commission or any other governmental or law enforcement agency. 

 (a) Confidential Information Defined. The term “Confidential Information”
includes, but is not limited to, any and all of Company’s trade secrets, confidential and proprietary information, and all other information and data of Company that is not generally known to the public or other third parties who could derive
economic value from its use or disclosure. Confidential Information includes, without limitation, technical information such as product specifications, compounds, formulas, improvements, discoveries, developments, designs, inventions, techniques,
new products and surgical training methods, and research and development information; confidential business methods and processes; business plans and strategies; marketing plans and strategies; non-public
financial information including budgets, sales data, sales forecasts, sales quotas, and information regarding profits or losses; office optimization and logistics information; information pertaining to current and prospective customers; information
pertaining to distributors and sales channel structures; pricing information; discount schedules; costing information; personnel information; compensation structure, schedules and plans; and information about current and prospective products or
services, whether or not reduced to writing or other tangible medium of expression, including work product created by Employee in rendering services for Company. 

(b) Non-Disclosure of Confidential Information. During Employee’s employment with Company
and thereafter, Employee will not disclose, transfer, or use (or seek to induce others to disclose, transfer, or use) any Confidential Information for any purpose other than (i) disclosure to authorized employees and agents of Company who are
bound to maintain the confidentiality of the Confidential Information; (ii) for authorized purposes during the course of Employee’s employment in furtherance of Company’s business; and/or (iii) as specifically allowed or required
under applicable law. Employee’s non-disclosure obligations shall continue as long as the Confidential Information remains confidential and shall not apply to information that becomes generally known to
the public through no fault or action of Employee. The Federal Defend Trade Secrets Act provides that individuals may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is
made (a) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney if such disclosure is made solely for the purpose of reporting or investigating a suspected violation of law or for
pursuing an anti-retaliation lawsuit; or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and the individual does not disclose the trade secret except pursuant to a court order. 

(c) Protection of Confidential Information. Employee will notify Company in writing of any circumstances which may constitute
unauthorized disclosure, transfer, or use of Confidential Information. Employee will use Employee’s best efforts to protect Confidential Information from unauthorized disclosure, transfer, or use. Employee will implement and abide by all
procedures adopted by Company to prevent unauthorized disclosure, transfer, or use of Confidential Information. Notwithstanding the above requirements, nothing in this Agreement shall restrict Employee’s right to make disclosures specifically
allowed or required under applicable law. 
 3. Intellectual Property. 

(a) Invention Defined. The term “Invention” includes, but is not limited to ideas, programs, processes, systems, intellectual
property, discoveries, and/or improvements which Employee discovers, invents, originates, develops, makes, or conceives alone or in conjunction with others which relate to Company’s present or future business during Employee’s employment
with Company and/or within six (6) months after Employee’s employment ends. An Invention is covered by this Agreement regardless of whether (i) Employee conceived of the Invention in the scope of Employee’s employment;
(ii) the Invention is patentable; or (iii) Company takes any action to commercialize or develop the Invention. 

  
 -2- 

 (b) Ownership of Inventions. Inventions are solely the property of Company. Employee
agrees that by operation of law and/or the effect of this Agreement, Employee does not have any rights, title, or interest in any Inventions. Notwithstanding, Employee may be recognized as the inventor of an Invention without retaining any other
rights associated therewith. 
 (c) Disclosure and Assignment of Inventions. Employee hereby assigns to Company all right, title and
interest Employee may have in any Inventions. Employee agrees to: (i) promptly disclose all such Inventions in writing to Company; (ii) keep complete and accurate records of all such Inventions, which records shall be Company property and
shall be retained on Company premises; and (iii) execute such documents and do such other acts as may be necessary in the opinion of Company to establish and preserve Company’s property rights in all such Inventions. This section shall not
apply to any Invention for which no equipment, supplies, facility, or Confidential Information of Company was used and which was developed entirely on Employee’s own time, and (1) which does not relate (a) directly to the business of
Company or (b) to Company’s actual or demonstrably anticipated research or development, and (2) which does not result from any work performed by Employee for Company. 

(d) Works of Authorship. All written, graphic or recorded material and all other works of authorship fixed in a tangible medium of
expression (including but not limited to computer software) made or created by Employee, solely or jointly with others, during Employee’s employment with Company and relating to Company’s business, actual or contemplated, shall be the
exclusive property of Company (collectively “Works”). Company will have the exclusive right to copyright such Works. Employee agrees that if any Work created by Employee while employed by Company, whether or not created at the direction of
Company, is copyrightable, such Work will be a “work made for hire,” as that term is defined in the copyright laws of the United States. If, for any reason, any copyrightable Works created by Employee are excluded from that definition,
Employee hereby assigns and conveys to Company all right, title, and interest (including any copyright and renewals) in such Works. 
 (e)
Attribution and Use of Works and Inventions; Waiver of Assertion of “Moral” Rights in Inventions and Works. Employee agrees that Company and its licensees are not required to designate Employee as author, inventor, or developer of
any Works or Inventions when distributed or otherwise. Employee hereby waives, and agrees not to assert, any “moral” rights in any Inventions and Works. Employee agrees that Company and its licensees shall have sole discretion with regard
to how and for what purposes any Inventions or Works are used or distributed. 

  
 -3- 

 (f) Employee Cooperation in Establishment of Company Proprietary Rights. Employee
will sign documents of assignment, declarations, and other documents and take all other actions reasonably required by Company, at Company’s expense, to perfect and enforce any of its proprietary rights. In the event Company is unable, for any
reason whatsoever, to secure Employee’s signature to any lawful or necessary documents required to apply for, prosecute, perfect, or assign any United States or foreign application for Letters Patent, trademark, copyright registration, or other
filing to protect any Invention or Work, Employee hereby irrevocably designates and appoints Company and its duly authorized officers and agents as Employee’s agent and attorney in fact, to act for and on Employee’s behalf, to execute and
file any such application, registration, or other filing, and to do all other lawfully permitted acts to further the prosecution, issuance, or assignment of Letters Patent or other protections on such Inventions, or registrations for trademark or
copyright or other protections on such Works, with the same force and effect as if executed by Employee. 
 4. Return of Confidential
Information and Company Property. Immediately upon termination of Employee’s employment with Company, Employee shall return to Company all of Company’s property relating to Company’s business, including without limitation all
of Company’s property which is in the possession, custody, or control of Employee such as Confidential Information, documents, hard copy files, copies of documents and electronic information/files, and equipment (e.g., computers and
mobile phones). 
 5. Obligations to Other Entities or Persons. Employee warrants that Employee is not bound by the terms of a
confidentiality agreement or any other legal obligation which would either preclude or limit Employee from disclosing or using any of Employee’s ideas, inventions, discoveries or other information or otherwise fulfilling Employee’s
obligations to Company. While employed by Company, Employee shall not disclose or use any confidential information belonging to another entity or other person. 

6. Conflict of Interest and Duty of Loyalty. During Employee’s employment with Company, Employee shall not engage, directly
or indirectly, in any activity, employment or business venture, whether or not for remuneration, that (i) is competitive with Company’s business; (ii) deprives or potentially could deprive Company of any business opportunity;
(iii) conflicts or potentially could conflict with Company’s business interests; or (iv) is otherwise detrimental to Company, including but not limited to preparations to engage in any of the foregoing activities. 

7. Restrictive Covenants.  

(a) Definitions. 
 (1)
“Competing Product” is defined as any implant, device, or medical product, instrument, supply, process, application, or service that is the same as, related to, or similar to any product, process, application, or service that Company is
researching, developing, manufacturing, distributing, selling, and/or providing at the time of Employee’s separation from employment with Company, including, but not limited to, the following Company product categories: dental, spine, bone
healing, surgical (including MIS solutions), and/or biologics. 

  
 -4- 

 (2) “Competing Organization” is defined as any organization that researches,
develops, manufactures, markets, distributes and/or sells one or more Competing Products. A Competing Organization is diversified if it operates multiple, independently operating business divisions, units, lines or segments some of which do not
research, develop, manufacture, market, distribute, and/or sell any Competing Products. 
 (3) “Prohibited Capacity” is defined as
(i) any same or similar capacity to that held by Employee at any time during Employee’s last two (2) years of employment with Company; (ii) any executive or managerial capacity; and/or (iii) any capacity in which
Employee’s knowledge of Confidential Information and/or Inventions would render Employee’s assistance to a Competing Organization a competitive advantage. 

(4) “Restricted Geographic Area” is defined as all countries, states, parishes or counties, municipalities, and territories in which
Company is doing business or is selling its products at the time of Employee’s separation from employment with Company, including but not limited to every parish and municipality in the state of Louisiana. Employee acknowledges that this
geographic scope is reasonable given Employee’s position with Company, the international scope of Company’s business, and the fact that Employee could compete with Company from anywhere Company does business. 

(5) “Restricted Period” is defined as the date Employee executes this Agreement, continuing eighteen (18) months after the
Employee’s last day of employment with Company unless otherwise extended by Employee’s breach of this Agreement. The running time on the Restricted Period shall be suspended during any period in which Employee is in violation of any of the
restrictive covenants set forth herein, and all restrictions shall automatically be extended by the period Employee was in violation of any such restrictions. 

(6) “Customer” is defined as any person or entity to whom or which Company sold or provided any products and/or services during the
last two (2) years of Employee’s employment with the Company. 
 (7) “Active Prospect” is defined as any person or
entity that Company individually and specifically marketed to and/or held discussions with regarding the research, development, manufacture, distribution, and/or sale of any Company products, processes, applications, or services at any time during
the last six (6) months of Employee’s employment with Company. 
 (8) “Severance Benefit Period” is the period of time
represented by the total amount of any severance benefit offered to Employee (whether or not actually paid). By way of illustration, if Employee were offered a lump-sum severance benefit equivalent to ten
(10) weeks of Employee’s final base pay upon termination of his or her employment with the Company, Employee’s Severance Benefit Period would be 10 weeks, whether or not Employee actually fulfilled all requirements of receiving, and
did receive, any portion of the severance benefit. 
 (b) Restrictive Covenants. During the Restricted Period, Employee agrees to be
bound by each of the following independent and divisible restrictions: 
 (1) Covenant Not to Compete. 

(A) Employee will not, within the Restricted Geographic Area, directly or indirectly, be employed by, work for, consult with, provide services
to, or lend assistance to any Competing Organization in a Prohibited Capacity. 

  
 -5- 

 (B) Employee may be employed by, work for, consult with, provide services to, or lend
assistance to a Competing Organization provided that: (i) the Competing Organization’s business is diversified; (ii) the part of the Competing Organization’s diversified business with which Employee will be affiliated would not,
evaluated on a stand-alone basis, be a Competing Organization; (iii) Employee’s affiliation with the Competing Organization does not involve any Competing Products; (iv) Employee provides Company a written description of
Employee’s anticipated activities on behalf of the Competing Organization which includes, without limitation, an assurance satisfactory to Company that Employee’s affiliation with the Competing Organization does not constitute a Prohibited
Capacity; and (v) Employee’s affiliation with the Competing Organization does not constitute a competitive disadvantage to Company. 

(C) If Employee, during the twelve (12) months preceding the last day of employment with Company, served in a product-specific role,
“Competing Product” shall be limited to those products with which Employee worked or about which Employee possessed Confidential Information (e.g. hip, knee, trauma) during any part of the twenty-four (24) month period preceding the
Employee’s last day of employment with Company. 
 (2) Covenant Not to Solicit Customers or Active Prospects. Employee will not,
directly or indirectly, (i) provide, sell, or market; (ii) attempt to provide, sell, or market; or (iii) assist any person or entity in the provision, sale, or marketing of any Competing Products to any Customers or Active Prospects
located in the Restricted Geographic Area. 
 (3) Covenant Not to Interfere with Business Relationships. Employee will not, within
the Restricted Geographic Area, urge, induce, or seek to induce any of Company’s independent contractors, subcontractors, distributors, brokers, consultants, sales representatives, customers, vendors, suppliers, or any other person or entity
with whom Company has a business relationship at the time of Employee’s separation from Company employment to terminate its or their relationship with, or representation of, Company or to cancel, withdraw, reduce, limit, or in any manner modify
any such person’s or entity’s business with, or representation of, Company 
 (4) Covenant Not to Solicit Company
Employees. Employee will not employ, solicit for employment, or advise any other person or entity to employ or solicit for employment, any individual (1) who is employed by Company at the time of Employee’s separation from Company and
(2) who has access to or possession of any Confidential Information that would give a Competing Organization an unfair advantage or otherwise directly or indirectly induce or entice any such individual to terminate his/her employment with
Company. 
 (5) Covenant Not to Disparage Company. Employee will not make or publish any disparaging or derogatory statements about
Company; about Company’s products, processes, applications, or services; or about Company’s past, present, or future officers, directors, employees, attorneys and agents. Disparaging or derogatory statements include, but are not limited
to, negative statements regarding Company’s business or other practices; provided, however, nothing herein shall prohibit Employee from providing any information as may be compelled by law or legal process. 

  
 -6- 

 8. Reasonableness of Terms. Employee acknowledges and agrees that the
restrictive covenants contained in this Agreement restrict Employee from engaging in activities for a competitive purpose and are reasonably necessary to protect Company’s legitimate interests in Confidential Information, Inventions, and
goodwill. Additionally, Employee acknowledges and agrees that the restrictive covenants are reasonable in all respects, including, but not limited to, temporal duration, scope of prohibited activities, and geographic area. Employee further
acknowledges and agrees that the restrictive covenants set forth in this Agreement will not pose unreasonable hardship on Employee and that Employee will have a reasonable opportunity to earn an equivalent livelihood without violating any provision
of this Agreement. 
 9. Non-Competition Period Payments. 

(a) Eligibility and Amount. In the event of Employee’s involuntary separation from employment with the Company for a reason that
renders Employee eligible for benefits under the terms of the Company’s Severance Plan, then to the extent Employee is denied, solely because of the restrictive covenant provisions of Section 7 of this Agreement, a specific full-time or
part-time employment, consulting, or other position that would otherwise be offered to Employee by a Competing Organization, and provided Employee satisfies all conditions stated herein, then upon expiration of the Severance Benefit
Period, Company will make monthly payments to Employee for each month Employee remains unemployed through the end of the Restricted Period. These monthly payments shall equal the lesser of Employee’s monthly base pay at the time of
Employee’s separation from Company employment (exclusive of bonus and other extra compensation and any other employee benefits) or the monthly compensation that would have been offered to Employee by the Competing Organization. This Section
will not apply if Employee leaves employment with the Company voluntarily or if Company terminates Employee’s employment for a reason or reasons that render Employee ineligible for benefits under terms of the Company’s Severance Plan. 

(b) Verification of Eligibility for Non-Competition Period Payments. To qualify for payments
under this Section, Employee must provide Company detailed written documentation supporting eligibility for payment, including, at a minimum, (i) the name and location of the Competing Organization that would have employed Employee but for the
provisions of Section 7 of this Agreement, (ii) the title, nature, and detailed job responsibilities of the employment position with the Competing Organization that Employee was denied, (iii) the date Employee was denied the
employment position, and (iv) the name and contact information of a managerial employee at the Competing Organization who has sufficient authority to confirm that Employee was denied this specific employment position with the Competing
Organization solely because Employee is subject to the provisions of Section 7 of this Agreement (“Eligibility Documentation”). Upon receipt of the Eligibility Documentation, Company will determine eligibility for payment and, if
eligibility is established, payments will commence as of the date of Company’s receipt of the Eligibility Documentation or the date the Severance Benefit Period ends, whichever is later. 

  
 -7- 

 (c) Obligation to Pursue Replacement Employment and Verification of Continued Eligibility
for Non-Competition Period Payments. Employee is obligated to diligently seek and pursue replacement employment that does not violate Section 7 of this Agreement (“Replacement Employment”)
during any period in which Employee seeks and/or accepts payment from Company under this Section. After eligibility for non-competition period payments is established, Employee will, on or before the 15th day of each month of eligibility for continued payments, submit to Company a written statement (i) identifying by name and address all prospective employers with whom Employee has applied or
inquired about employment; (ii) identifying positions sought or applied for with each listed employer and specific actions taken in seeking each position; (iii) describing all other efforts made to obtain Replacement Employment; and
(iv) describing any offers of employment received, including the name of the employer; the nature, title, and compensation terms of the position offered; whether the offer has been accepted and if so the actual or anticipated start date; and if
the offer was declined, the reason(s) for declining. 
 (d) Effect of Replacement Employment on
Non-Competition Period Payments. If Employee is denied a specific employment, consulting or other such position with a Competing Organization solely because of the restrictive covenant provisions of
Section 7 of this Agreement but obtains Replacement Employment for compensation, and the monthly compensation (including base pay, commissions, incentive compensation, bonuses, fees and other compensation) for the Replacement Employment is less
than Employee’s monthly base pay as was in effect at the time of the termination of Employee’s employment with the Company, Company agrees to pay Employee the difference for each such month through the end of the Restricted Period, again
upon expiration of Employee’s Severance Benefit Period and provided Employee satisfies all conditions stated herein. Employee shall submit to Company payroll records and/or any other records reasonably requested by Company showing all
compensation received by Employee from the Replacement Employment as a condition of Company’s payment of Non-Competition Period Payments covering any period of time when Employee performs work for
compensation. 
 (e) Company’s Right to Provide Release of Obligations in Lieu of
Non-Competition Period Payments. Notwithstanding any of the foregoing provisions of this Section, Company reserves the right to release Employee from Employee’s obligations under Section 7 of
this Agreement at any time during the Restricted Period, in full or in sufficient part to allow Employee to accept an opportunity that would otherwise be prohibited under this Agreement, at which time Company’s payment obligations under this
Section shall cease immediately and Employee shall not be entitled to any further such payments or compensation. 
 10. Severability,
Modification of Restrictions. The covenants and restrictions in this Agreement are separate and divisible, and to the extent any covenant, provision, or clause of this Agreement is determined to be unenforceable or invalid for any reason,
Company and Employee acknowledge and agree that such unenforceability or invalidity shall not affect the enforceability or validity of the remainder of the Agreement. If any particular covenant, provision, or clause of this Agreement is determined
to be unreasonable or unenforceable for any reason, including, without limitation, temporal duration, scope of prohibited activity, and/or scope of geographic area, Company and Employee acknowledge and agree that such covenant, provision, or clause
shall automatically be deemed reformed to have the closest effect permitted by applicable law to the original form and shall be given effect and enforced as so reformed to whatever extent would be reasonable and enforceable under applicable law. The
parties agree that any court interpreting the provisions of this Agreement shall have the authority, if necessary, to reform any such provision to make it enforceable under applicable law. 

  
 -8- 

 11. Remedies. Employee acknowledges that a breach or threatened breach by
Employee of this Agreement will give rise to irreparable injury to Company and that money damages will not be adequate relief for such injury. Accordingly, Employee agrees that Company shall be entitled to obtain injunctive relief, including, but
not limited to, temporary restraining orders, preliminary injunctions and/or permanent injunctions, without having to post any bond or other security, to restrain or prohibit such breach or threatened breach, in addition to any other legal remedies
which may be available. In addition to all other relief to which it shall be entitled, Company shall be entitled to cease all payments to which Employee would otherwise be entitled under Section 9 hereto; continue to enforce this Agreement;
recover from Employee all payments made under Section 9 to the extent attributable to a time during which Employee was in violation of the covenants for which payment was made; and recover from Employee all litigation costs and attorneys’
fees incurred by Company in any action or proceeding relating to this Agreement in which Company prevails in any respect, including, but not limited to, any action or proceeding in which Company seeks enforcement of this Agreement or seeks relief
from Employee’s violation of this Agreement. 
 12. Survival of Obligations. Employee acknowledges and agrees that
Employee’s obligations under this Agreement, including, without limitation, Employee’s non-disclosure and non-competition obligations, shall survive the
termination of Employee’s employment with Company, whether such termination is with or without cause and whether it is voluntary or involuntary. Employee acknowledges and agrees that nothing in this Agreement alters the at-will nature of Employee’s employment and that either Company or Employee may terminate the employment relationship at any time, with or without cause or notice. Employee further acknowledges and agrees that:
(a) Employee’s non-disclosure, non-disparagement, non-solicitation, and
non-competition covenants set forth in Sections 2 and 7 of this Agreement shall be construed as independent covenants and that no breach of any contractual or legal duty by Company shall be held sufficient to
excuse or terminate Employee’s obligations or to preclude Company from obtaining injunctive relief or other remedies for Employee’s violation or threatened violation of such covenants, and (b) the existence of any claim or cause of
action by Employee against Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to Company’s enforcement of Employee’s obligations under Sections 2 and 7 of this Agreement. 

13. Governing Law and Choice of Forum. This Agreement shall be construed and enforced in accordance with the laws of the State of
Delaware, notwithstanding any state’s choice-of-law rules to the contrary. The parties agree that this Agreement is deemed to have been entered into in the State of
Delaware and the State of Delaware has a material interest in the consistent enforcement of Company’s agreements. Accordingly, the parties agree that any legal action relating to this Agreement shall be commenced and maintained exclusively
before the United States District Court for the District of Delaware if jurisdiction permits, or otherwise before any appropriate state court located in Delaware. The parties hereby submit to the jurisdiction of such courts and waive any right to
challenge or otherwise object to personal jurisdiction or venue, in any action commenced or maintained in such courts. Language translations aside, the English version shall govern. 

  
 -9- 

 14. Enforcement. The parties agree that Zimmer Biomet Spine, Inc. and/or any
or each of its affiliates, parents, or direct or indirect, as well as any successor-in-interest to Zimmer Biomet Spine, Inc. and/or to any of its direct or indirect
subsidiaries, affiliates, or parents are express and intended parties to and beneficiaries of this Agreement, with full rights to enforce this Agreement independently or in conjunction with each other. 

15. State Law Addenda. Certain terms of this Agreement shall be modified for certain employees as set forth in Addenda A-F to this Agreement. 
 16. Successors and Assigns. Company shall have the right to assign
this Agreement, and, accordingly, this Agreement shall inure to the benefit of, and may be enforced by, any and all successors and assigns of Company, including without limitation by asset assignment, stock sale, merger, consolidation or other
corporate reorganization, and shall be binding on Employee. The services to be provided by Employee to Company are personal to Employee, and Employee shall not have the right to assign Employee’s duties under this Agreement. 

17. Modification. This Agreement may not be amended, supplemented, or modified except by a written document signed by both
Employee and a duly authorized officer of Company. 
 18. No Waiver. The failure of Company to insist in any one or more
instances upon performance of any provision of this Agreement or to pursue its rights hereunder shall not be construed as a waiver of any such provisions or the relinquishment of any such rights. 

19. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but both of which
when taken together will constitute one and the same agreement. 
 20. Entire Agreement. This Agreement, including Recitals,
constitutes the entire agreement of the parties with respect to the subjects specifically addressed herein, and supersedes any prior agreements, understandings, or representations, oral or written, on the subjects addressed herein. Notwithstanding
the foregoing, to the extent the employee has an existing non-competition, confidentiality, and/or non-solicitation agreement in favor of Company and has breached or
violated the terms thereof, Company may continue to enforce its rights and remedies under and pursuant to such existing agreement. 

  
 -10- 

 Employee’s signature below indicates that Employee has read the entire Agreement,
understands what Employee is signing, and is signing the Agreement voluntarily. Employee has the right to consult with counsel prior to signing this Agreement, and agrees that Company advised Employee to consult with an attorney prior to signing the
Agreement. 
  

			
	“EMPLOYEE”
	
	  
 (Employee
Signature)

		
	Printed Name:	 	  

		
	Date:	 	  

  

			
	“COMPANY”
	
	  
 (Company Representative
Signature)

		
	Printed Name:	 	  

		
	Title:	 	  

		
	Date:	 	  

  
 -11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]